Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Nabors · SciRah

Researcher profile · Semantic Scholar

B. Nabors

Share profile

B. Nabors — researcher profile on SciRah

h-index: 20
Works: 110
Citations: 1,809

Most-cited papers

Vorasidenib in IDH1- or IDH2-mutant Low-Grade Glioma
I. Mellinghoff, M. J. van den Bent, D. Blumenthal, M. Touat +26 more
2023New England Journal of Medicine472 citations Open access
Semantic Scholar
Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma
Hirokazu Sadahiro, Kyung-Don Kang, Justin T. Gibson, M. Minata +24 more
2018Cancer Research132 citations Open access
Semantic Scholar
Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.
Nathaniel H. Boyd, Kiera Walker, Joshua S. Fried, J. Hackney +20 more
2017JCI Insight110 citations Open access
Semantic Scholar
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study.
Chandrakanth Jayachandran Preetha, Hagen Meredig, G. Brugnara, M. Mahmutoglu +24 more
2021The Lancet Digital Health95 citations Open access
Semantic Scholar
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma
I. Arrillaga-Romany, A. Lassman, S. McGovern, Sabine Mueller +8 more
2024Neuro-Oncology63 citations Open access
Semantic Scholar
Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
Daxa M. Patel, P. Foreman, B. Nabors, Kristen O. Riley +2 more
2016Human Gene Therapy Clinical Development59 citations Open access
Semantic Scholar
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071–22072 and CORE Trials
J. Furtner, M. Weller, Michael Weber, T. Gorlia +5 more
2021Clinical Cancer Research56 citations Open access
Semantic Scholar
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis
C. Seliger, E. Genbrugge, T. Gorlia, O. Chinot +4 more
2020International Journal of Cancer53 citations Open access
Semantic Scholar
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1
C. Lucas, Emily A. Sloan, Rohit Gupta, Jasper Wu +38 more
2022Acta Neuropathologica42 citations Open access
Semantic Scholar
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study.
Aditya Rastogi, G. Brugnara, Martha Foltyn-Dumitru, M. Mahmutoglu +25 more
2024The Lancet Oncology38 citations Open access
Semantic Scholar
NCCN CNS Tumor Guidelines Update for 2023.
B. Nabors, J. Portnow, J. Hattangadi-Gluth, C. Horbinski
2023Neuro-Oncology35 citations
Semantic Scholar
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors
C. Horbinski, D. Solomon, R. Lukas, R. Packer +18 more
2024JAMA Oncology34 citations Open access
Semantic Scholar
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial.
T. Cloughesy, M. J. van den Bent, M. Touat, D. Blumenthal +29 more
2025The Lancet Oncology31 citations Open access
Semantic Scholar
Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma Cells
P. Che, Lei Yu, G. Friedman, Meimei Wang +6 more
2021Cancers29 citations Open access
Semantic Scholar
Implementing a Clinic-Based Telehealth Support Service (FamilyStrong) for Family Caregivers of Individuals with Grade IV Brain Tumors
J. Dionne-Odom, Grant R. Williams, P. Warren, Sheri Tims +14 more
2020Journal of Palliative Medicine26 citations Open access
Semantic Scholar
Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review
K. Piper, Haidn Foster, B. Gabel, B. Nabors +1 more
2019Frontiers in Oncology20 citations Open access
Semantic Scholar
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.
É. Le Rhun, Felix Boakye Oppong, M. Vanlancker, R. Stupp +6 more
2022Neuro-Oncology17 citations Open access
Semantic Scholar
CTIM-13. PHASE I CLINICAL TRIAL OF ONCOLYTIC HSV-1 M032, A SECOND-GENERATION VIRUS ARMED TO EXPRESSED IL-12, FOR THE TREATMENT OF ADULT PATIENTS WITH RECURRENT OR PROGRESSIVE MALIGNANT GLIOMA
D. Estevez-Ordonez, John Stein, P. Maleknia, Carlos Gallegos +11 more
2023Neuro-Oncology14 citations Open access
Semantic Scholar
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.
Patrick Y. Wen, D. Berry, M. Buxton, H. Colman +28 more
2026Journal of Clinical Oncology13 citations Open access
Semantic Scholar
Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis
Zhong Liu, P. Che, J. Mercado, J. Hackney +13 more
2018Journal of Neuro-Oncology13 citations Open access
Semantic Scholar
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?
M. Geurts, L. Berchtold, Franz König, B. Nabors +6 more
2025Neuro-Oncology Practice11 citations Open access
Semantic Scholar
OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB
A. Lassman, B. Alexander, D. Berry, M. Buxton +32 more
2024Neuro-Oncology11 citations Open access
Semantic Scholar
Association of antidepressant drug use with outcome of patients with glioblastoma
C. Seliger, Felix Boakye Oppong, F. Lefranc, O. Chinot +4 more
2022International Journal of Cancer11 citations Open access
Semantic Scholar
CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB
Patrick Y. Wen, B. Alexander, D. Berry, M. Buxton +32 more
2023Neuro-Oncology8 citations Open access
Semantic Scholar
LTBK-09. RESULTS OF BMX-HGG STUDY: A MULTI-INSTITUTIONAL, RANDOMIZED PHASE 2 CLINICAL TRIAL OF CONCURRENT CHEMORADIATION WITH OR WITHOUT BMX-001 IN PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMA
K. Peters, Adam Cohen, N. Butowski, J. Villano +19 more
2023Neuro-Oncology8 citations Open access
Semantic Scholar
Using cognition to predict the ability to understand medical treatment in brain and metastatic cancer
A. Gerstenecker, M. Gammon, Dario A. Marotta, J. Fiveash +3 more
2019Psycho-Oncology8 citations
Semantic Scholar
Cauda equina syndrome in an ovarian malignant‐mixed müllerian tumor with leptomeningeal spread
J. Bernstock, S. Ostby, B. Fox, H. Sotoudeh +11 more
2019Clinical Case Reports7 citations Open access
Semantic Scholar
The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study
Yi-Fei Sun, D. Estevez-Ordonez, T. Atchley, B. Nabors +1 more
2025Journal of Neuro-Oncology6 citations Open access
Semantic Scholar
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT
M. Ahluwalia, A. Ozair, J. Drappatz, Xiao-Bu Ye +18 more
2024Clinical Cancer Research6 citations Open access
Semantic Scholar
CTNI-53. A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS
I. Mellinghoff, M. J. van den Bent, M. Touat, D. Blumenthal +25 more
2024Neuro-Oncology6 citations Open access
Semantic Scholar
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)
M. Ahluwalia, A. Ozair, M. Rudek, Xiao-Bu Ye +12 more
2024Cell Reports Medicine6 citations
Semantic Scholar
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
S. Ryu, Xiao-Bu Ye, Jeffrey J. Olson, T. Mikkelsen +7 more
2024Neuro-Oncology Advances6 citations Open access
Semantic Scholar
A Randomized, Double-blind, Phase 3 Study of Vorasidenib Versus Placebo in Patients with Mutant IDH1/2 Diffuse Glioma (INDIGO): Analysis of Health-related Quality of Life, Neurocognition and Seizures (PL5.003)
K. Peters, I. Mellinghoff, M. J. van den Bent, D. Blumenthal +25 more
2024Neurology6 citations
Semantic Scholar
Capacity to consent to research participation in adults with metastatic cancer: comparisons of brain metastasis, non-CNS metastasis, and healthy controls.
Kyler Mulhauser, Dario A. Marotta, A. Gerstenecker, Gabrielle Wilhelm +6 more
2020Neuro-Oncology Practice6 citations Open access
Semantic Scholar
American Association of Neuropathologists, Inc. Abstracts of the 94th Annual Meeting, June 7–10, 2018 Louisville, Kentucky
Raymond A. Sobel, Mary J. Eaton, J. Hinojoza, M. Touat +37 more
2018Journal of Neuropathology and Experimental Neurology6 citations
Semantic Scholar
Brain Tumors in United States Military Veterans.
J. Bihn, G. Cioffi, K. Waite, C. Kruchko +18 more
2023Neuro-Oncology5 citations Open access
Semantic Scholar
Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas.
J. Jo, M. J. van den Bent, B. Nabors, P. Wen +1 more
2022Neuro-Oncology5 citations Open access
Semantic Scholar
ATIM-11. PHASE 2 TRIAL OF SL-701, A NOVEL IMMUNOTHERAPY COMPRISED OF SYNTHETIC SHORT PEPTIDES AGAINST GBM TARGETS IL-13Rα2, EphA2, AND SURVIVIN, IN ADULTS WITH SECOND-LINE RECURRENT GBM: INTERIM RESULTS
D. Reardon, D. Peereboom, B. Nabors, K. Fink +19 more
20165 citations Open access
Semantic Scholar
STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma
H. Colman, G. Lombardi, Eric T Wong, T. Walbert +25 more
2025Journal of Clinical Oncology4 citations Open access
Semantic Scholar
CTNI-41. PHASE II AND PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS
David Schiff, R. Bindra, Jing Li, Xiao-Bu Ye +12 more
2023Neuro-Oncology4 citations Open access
Semantic Scholar
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
K. Seystahl, Felix Boakye Oppong, É. Le Rhun, Caroline Hertler +6 more
2022Neuro-Oncology Advances4 citations Open access
Semantic Scholar
A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases
J. Fiveash, W. Arafat, G. Naoum, B. Guthrie +6 more
2016Advances in Radiation Oncology4 citations Open access
Semantic Scholar
Survival outcomes associated with antidepressant use in glioblastoma: a cohort study
Yi-Fei Sun, M. Hamo, T. Atchley, James Markert +2 more
2025Journal of Neuro-Oncology3 citations Open access
Semantic Scholar
The effect of antidepressants on glioblastoma survival: A systematic review and meta-analysis
Yi-Fei Sun, M. Hamo, T. Atchley, B. Nabors +2 more
2025Neuro-Oncology Advances3 citations
Semantic Scholar
LTBK-01. PHASE 3 STELLAR STUDY SHOWS EFLORNITHINE IMPROVES OVERALL SURVIVAL (OS) AND PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH RECURRENT 2021 WHO ASTROCYTOMA, IDH-MUTANT GRADE 3
H. Colman, G. Lombardi, E. Wong, T. Walbert +24 more
2024Neuro-Oncology3 citations Open access
Semantic Scholar
Lisavanbulin (BAL101553), a novel microtubule inhibitor, plus radiation in patients with newly diagnosed, MGMT promoter unmethylated glioblastoma
M. Holdhoff, Xiao-Bu Ye, Roy E. Strowd, B. Nabors +13 more
2024Neuro-Oncology Advances3 citations Open access
Semantic Scholar
MODL-06. THE GUT MICROBIOTA OF BRAIN TUMOR PATIENTS CAN IMPACT IMMUNOTHERAPY EFFICACY IN A PRECLINICAL MODEL OF GLIOMA
Donggeon Kim, Sujith Sarvesh, Olivia Valbak, Olivia Backan +12 more
2023Neuro-Oncology3 citations Open access
Semantic Scholar
Evaluating “brain permeability”: A critical issue for the development of therapeutic agents for primary and metastatic brain tumors
Stuart A. Grossman, A. Barone, R. Strowd, R. Rais +18 more
2026Neuro-Oncology2 citations Open access
Semantic Scholar
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma
É. Le Rhun, D. Sain, S. Erridge, D. Reardon +12 more
2025JAMA Network Open2 citations Open access
Semantic Scholar
Pilot Study of Glucarpidase in Combination with Rituximab and Methotrexate (MTX) in CNS Lymphoma (CNSL) (1409)
L. Schaff, U. Sener, I. Gavrilovic, Alexandra M. Miller +10 more
2020Neurology2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Gorlia×9
Invite
T. Gorlia — researcher profile on SciRah
T. Walbert×9
Invite
T. Walbert — researcher profile on SciRah
I. Mellinghoff×8
Invite
I. Mellinghoff — researcher profile on SciRah
M. J. van den Bent×8
Invite
M. J. van den Bent — researcher profile on SciRah

×8

Invite

R. Stupp — researcher profile on SciRah

M. I. de la Fuente×7

Invite

M. I. de la Fuente — researcher profile on SciRah

Invite

M. Touat — researcher profile on SciRah

Invite

A. Lassman — researcher profile on SciRah

Invite

N. Butowski — researcher profile on SciRah

J. D. de Groot×5

Invite

J. D. de Groot — researcher profile on SciRah

B. Ellingson×5

Invite

B. Ellingson — researcher profile on SciRah

Invite

P. Giglio — researcher profile on SciRah